MedStar Authors catalog › Details for: Universal Rapid Human Immunodeficiency Virus Screening at Delivery: A Cost-Effectiveness Analysis.
Normal view MARC view ISBD view

Universal Rapid Human Immunodeficiency Virus Screening at Delivery: A Cost-Effectiveness Analysis.

by Scott, Rachel K; Huang, Chun Chih.
Citation: Infectious Diseases in Obstetrics & Gynecology. 2018:6024698, 2018..Journal: Infectious diseases in obstetrics and gynecology.Published: 2018ISSN: 1064-7449.Full author list: Scott RK; Crochet S; Huang CC.UI/PMID: 29731602.Subject(s): IN PROCESS -- NOT YET INDEXEDInstitution(s): MedStar Health Research InstituteActivity type: Journal Article.Medline article type(s): Journal ArticleOnline resources: Click here to access online Digital Object Identifier: https://dx.doi.org/10.1155/2018/6024698 (Click here) ORCID: Scott, Rachel K https://orcid.org/0000-0002-1519-9222 (Click here) Abbreviated citation: Infect Dis Obstet Gynecol. 2018:6024698, 2018.Local Holdings: Available online from MWHC library: 1998 - present.Abstract: Objective: To determine the cost-effectiveness of universal maternal HIV screening at time of delivery to decrease mother-to-child transmission (MTCT), by comparing the cost and quality-adjusted life years (QALYs) of universal rapid HIV screening at time of delivery to two current standards of care for prenatal HIV screening in the United States.Abstract: Study Design: We conducted a cost-effectiveness analysis to compare the cost and QALY of universal intrapartum rapid HIV screening with two current standards of care: (I) opt-out rapid HIV testing limited to patients without previous third-trimester screening and (II) opt-out rapid HIV testing limited to patients without any prenatal screening. We developed a decision-tree model and performed sensitivity analyses to estimate the impact of variances in QALY, estimated lifetime medical costs, HIV prevalence, and cumulative incidence.Abstract: Results: The incremental cost-effectiveness ratio for universal screening was Abstract: Conclusions: Intrapartum universal rapid HIV screening to decrease MTCT appears cost-effective in populations with high HIV incidence in the United States.

Powered by Koha